OPKO Health (OPK) Interest Coverage Ratio: History & Chart

OPKO Health, Inc.(OPK)

Medical - Diagnostics & Research · Miami, FL

$1.51-0.06 (-4.13%)

Delayed quote: Oct 6, 2026, 1:15 PM EDT

About OPKO Health, Inc.

OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diagnostics division encompasses BioReference Laboratories, which delivers a comprehensive suite of laboratory testing services. These services are crucial for disease detection, diagnosis, evaluation, monitoring, and treatment, covering areas such as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare. BioReference serves a diverse client base, including medical practices, clinics, hospitals, employers, and government entities. Additionally, this segment provides a cutting-edge diagnostic instrument system designed for immediate, point-of-care blood test results, alongside its specialized 4Kscore testing for prostate cancer. Within the Pharmaceutical segment, OPKO offers a range of therapeutic products and a robust development pipeline. Key offerings include Rayaldee, indicated for the management of secondary hyperparathyroidism in adults suffering from stage 3 or 4 chronic kidney disease and vitamin D insufficiency. The pipeline features OPK88004, an investigational orally administered selective androgen receptor modulator; OPK88003, a peptide administered once weekly currently in Phase IIb trials for the treatment of type 2 diabetes and obesity; and hGH-CTP, a once-weekly human growth hormone injection that has successfully completed Phase III clinical trials in collaboration with Pfizer, Inc. A core strategy for this segment involves the development and commercialization of proprietary, extended-release versions of existing therapeutic proteins. Furthermore, OPKO Health supplies specialty active pharmaceutical ingredients (APIs) and is involved in the development, manufacturing, marketing, and sale of pharmaceutical, nutraceutical, veterinary, and ophthalmic products. The company also commercializes food supplements and over-the-counter products, produces and sells items primarily within the generics market, and handles the import, marketing, distribution, and sales of pharmaceutical products across various therapeutic areas, including cardiovascular conditions, vaccines, antibiotics, gastro-intestinal ailments, and hormone-related treatments, among others. Its pharmaceutical operations are further bolstered by platforms situated in Ireland, Chile, Spain, and Mexico. Founded in 1991, OPKO Health, Inc. maintains its corporate headquarters in Miami, Florida.

Miami, FL

2,275 employees

www.opko.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Phillip Frost

View full financials

OPK Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

-2.02x

INTEREST COVERAGE RATIO AVG TTM

-2.85x

INTEREST COVERAGE RATIO AVG 3Y

-3.16x

INTEREST COVERAGE RATIO AVG 5Y

-7.81x

INTEREST COVERAGE RATIO AVG 10Y

-9.14x

INTEREST COVERAGE RATIO AVG 15Y

-11.13x

INTEREST COVERAGE RATIO AVG 20Y

-11.13x

CURRENT VS TTM AVG

+29.02%

CURRENT VS 3Y AVG

+36.10%

CURRENT VS 5Y AVG

+74.14%

CURRENT VS 10Y AVG

+77.90%

CURRENT VS 15Y AVG

+81.85%

CURRENT VS 20Y AVG

+81.85%

SECTOR MEDIAN · HEALTHCARE

-5.90x

median of 496 covered companies

CURRENT VS SECTOR MEDIAN

+65.76%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
OPKO Health, Inc. (OPK)	$1.12B	-2.02x	-2.85x	-3.16x	-7.81x
Avalyn Pharma Inc. Common Stock (AVLN)vs ›	$1.12B	N/A	N/A	N/A	N/A
Harrow Health, Inc. (HROW)vs ›	$1.13B	1.60x	1.00x	0.57x	0.46x
Amphastar Pharmaceuticals, Inc. (AMPH)vs ›	$1.13B	5.51x	6.14x	19.44x	31.00x
STAAR Surgical Company (STAA)vs ›	$1.11B	N/A	877.34x	877.34x	877.34x
GoodRx Holdings, Inc. (GDRX)vs ›	$1.14B	2.05x	1.65x	1.11x	0.98x
Nektar Therapeutics (NKTR)vs ›	$1.14B	-4.99x	16.08x	16.08x	16.08x
Replimune Group, Inc. (REPL)vs ›	$1.09B	-36.11x	N/A	N/A	N/A
Bicara Therapeutics Inc. Common Stock (BCAX)vs ›	$1.09B	N/A	N/A	N/A	N/A
IRadimed Corporation (IRMD)vs ›	$1.08B	N/A	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

OPKO Health, Inc. (OPK)

$1.12B

-2.02x

-2.85x

-3.16x

-7.81x

Avalyn Pharma Inc. Common Stock (AVLN)vs ›

$1.12B

N/A

Harrow Health, Inc. (HROW)vs ›

$1.13B

1.60x

1.00x

0.57x

0.46x

Amphastar Pharmaceuticals, Inc. (AMPH)vs ›

$1.13B

5.51x

6.14x

19.44x

31.00x

STAAR Surgical Company (STAA)vs ›

$1.11B

N/A

877.34x

GoodRx Holdings, Inc. (GDRX)vs ›

$1.14B

2.05x

1.65x

1.11x

0.98x

Nektar Therapeutics (NKTR)vs ›

$1.14B

-4.99x

16.08x

Replimune Group, Inc. (REPL)vs ›

$1.09B

-36.11x

N/A

Bicara Therapeutics Inc. Common Stock (BCAX)vs ›

$1.09B

N/A

IRadimed Corporation (IRMD)vs ›

$1.08B

N/A

Interest Coverage Ratio FAQ

What is the interest coverage ratio for OPKO Health, Inc. (OPK)?

The interest coverage ratio for OPK stock is -2.02x.

Is OPKO Health, Inc.'s interest coverage ratio high or low?

The interest coverage ratio of -2.02x is 74% above its 5-year average of -7.81x, near the high end of its 5-year range (-29.11x–8.82x).

What is the TTM average interest coverage ratio for OPKO Health, Inc. (OPK)?

The TTM average interest coverage ratio for OPK stock is -2.85x.

What is the 3Y average interest coverage ratio for OPKO Health, Inc. (OPK)?

The 3Y average interest coverage ratio for OPK stock is -3.16x.

What is the 5Y average interest coverage ratio for OPKO Health, Inc. (OPK)?

The 5Y average interest coverage ratio for OPK stock is -7.81x.

What is the 10Y average interest coverage ratio for OPKO Health, Inc. (OPK)?

The 10Y average interest coverage ratio for OPK stock is -9.14x.

What is the 15Y average interest coverage ratio for OPKO Health, Inc. (OPK)?

The 15Y average interest coverage ratio for OPK stock is -11.13x.

What is the 20Y average interest coverage ratio for OPKO Health, Inc. (OPK)?

The 20Y average interest coverage ratio for OPK stock is -11.13x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	-0.61x
2026-03-31	-4.66x
2025-12-31	-3.39x
2025-09-30	-4.71x
2025-06-30	-0.85x
2025-03-31	-4.34x
2024-12-31	-2.33x
2024-09-30	0.82x
2024-06-30	-7.54x
2024-03-31	-9.30x
2023-12-31	-20.00x
2023-09-30	-19.03x
2023-06-30	2.14x
2023-03-31	-9.02x
2022-12-31	-16.74x
2022-09-30	-29.11x
2022-06-30	-3.49x
2022-03-31	-27.21x
2021-12-31	-14.64x
2021-09-30	8.82x
2021-06-30	1.14x
2021-03-31	7.12x
2020-12-31	9.10x
2020-09-30	3.96x
2020-06-30	4.97x
2020-03-31	-7.42x
2019-12-31	-20.57x
2019-09-30	-6.74x
2019-06-30	-8.59x
2019-03-31	-15.84x
2018-12-31	-22.75x
2018-09-30	-11.37x
2018-06-30	-1.88x
2018-03-31	-18.80x
2017-09-30	-31.68x
2017-06-30	-17.20x
2017-03-31	-29.19x
2016-12-31	-35.80x
2016-09-30	-11.71x
2016-06-30	12.75x
2016-03-31	-15.40x
2015-12-31	-3.72x
2015-09-30	-3.00x
2015-06-30	-25.77x
2015-03-31	-22.19x
2014-12-31	-19.19x
2014-09-30	-20.07x
2014-06-30	-7.45x
2014-03-31	-8.69x
2013-12-31	-9.82x
2013-09-30	-5.58x
2013-06-30	-4.68x
2013-03-31	-2.34x
2012-12-31	-22.59x
2012-09-30	-23.84x
2012-06-30	-40.44x
2012-03-31	-25.21x
2011-09-30	-12.73x
2011-06-30	-18.44x
2011-03-31	-48.34x
2005-12-31	-215.00x

DATE

INTEREST COVERAGE RATIO

2026-06-30

-0.61x

2026-03-31

-4.66x

2025-12-31

-3.39x

2025-09-30

-4.71x

2025-06-30

-0.85x

2025-03-31

-4.34x

2024-12-31

-2.33x

2024-09-30

0.82x

2024-06-30

-7.54x

2024-03-31

-9.30x

2023-12-31

-20.00x

2023-09-30

-19.03x

2023-06-30

2.14x

2023-03-31

-9.02x

2022-12-31

-16.74x

2022-09-30

-29.11x

2022-06-30

-3.49x

2022-03-31

-27.21x

2021-12-31

-14.64x

2021-09-30

8.82x

2021-06-30

1.14x

2021-03-31

7.12x

2020-12-31

9.10x

2020-09-30

3.96x

2020-06-30

4.97x

2020-03-31

-7.42x

2019-12-31

-20.57x

2019-09-30

-6.74x

2019-06-30

-8.59x

2019-03-31

-15.84x

2018-12-31

-22.75x

2018-09-30

-11.37x

2018-06-30

-1.88x

2018-03-31

-18.80x

2017-09-30

-31.68x

2017-06-30

-17.20x

2017-03-31

-29.19x

2016-12-31

-35.80x

2016-09-30

-11.71x

2016-06-30

12.75x

2016-03-31

-15.40x

2015-12-31

-3.72x

2015-09-30

-3.00x

2015-06-30

-25.77x

2015-03-31

-22.19x

2014-12-31

-19.19x

2014-09-30

-20.07x

2014-06-30

-7.45x

2014-03-31

-8.69x

2013-12-31

-9.82x

2013-09-30

-5.58x

2013-06-30

-4.68x

2013-03-31

-2.34x

2012-12-31

-22.59x

2012-09-30

-23.84x

2012-06-30

-40.44x

2012-03-31

-25.21x

2011-09-30

-12.73x

2011-06-30

-18.44x

2011-03-31

-48.34x

2005-12-31

-215.00x

Interest Coverage Ratio: -2.02x

OPK Interest Coverage Ratio

OPK Average Interest Coverage Ratio Chart

OPK Current vs Average Interest Coverage Ratio Chart

OPK Interest Coverage Ratio Metrics

OPK Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

OPK Interest Coverage Ratio History

Related Metrics